Insider · CIK 0001788524

Thompson Rahsaan

Reports to the SEC for 4 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001788524

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-14	ZVRAZEVRA THERAPEUTICS, INC.S Sale	Chief Legal & Compliance	SSale	−42.7K sh	$11.13	−$475K	37,569
2026-06-22	ZVRAZEVRA THERAPEUTICS, INC.S Sale	Chief Legal & Compliance	SSale	−34.6K sh	$12.68	−$438K	80,235
2026-06-21	ZVRAZEVRA THERAPEUTICS, INC.M Exercise/Conversion	Chief Legal & Compliance	MExercise/Conversion	+66.7K sh	—	—	114,792
2026-06-21	ZVRAZEVRA THERAPEUTICS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Legal & Compliance	MExercise/Conversion	−66.7K sh	—	—	66,667
2026-05-11	ZVRAZEVRA THERAPEUTICS, INC.S Sale	Chief Legal & Compliance	SSale	−1,794 sh	$11.30	−$20.3K	48,125
2026-01-30	ZVRAZEVRA THERAPEUTICS, INC.M Exercise/Conversion	Chief Legal & Compliance	MExercise/Conversion	+11.3K sh	—	—	53,999
2026-01-30	ZVRAZEVRA THERAPEUTICS, INC.S Sale	Chief Legal & Compliance	SSale	−4,080 sh	$8.83	−$36K	49,919
2026-01-30	ZVRAZEVRA THERAPEUTICS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Legal & Compliance	MExercise/Conversion	−11.3K sh	—	—	22,667
2026-01-29	ZVRAZEVRA THERAPEUTICS, INC. · Restricted Stock UnitA Award	Chief Legal & Compliance	AAward	+37.5K sh	—	—	37,500
2026-01-29	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Legal & Compliance	AAward	+75K sh	—	—	75,000
2025-06-26	ZVRAZEVRA THERAPEUTICS, INC.S Sale	Chief Legal & Compliance	SSale	−24K sh	$9.21	−$221K	42,666
2025-06-21	ZVRAZEVRA THERAPEUTICS, INC.M Exercise/Conversion	Chief Legal & Compliance	MExercise/Conversion	+66.7K sh	—	—	66,666
2025-06-21	ZVRAZEVRA THERAPEUTICS, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Legal & Compliance	MExercise/Conversion	−66.7K sh	—	—	133,334
2025-01-30	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Legal & Compliance	AAward	+68K sh	—	—	68,000
2025-01-30	ZVRAZEVRA THERAPEUTICS, INC. · Restricted Stock UnitA Award	Chief Legal & Compliance	AAward	+34K sh	—	—	34,000
2024-06-21	ZVRAZEVRA THERAPEUTICS, INC. · Restricted Stock UnitA Award	Chief Legal & Compliance	AAward	+200K sh	—	—	200,000
2023-02-24	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Chief Legal Officer	AAward	+245K sh	—	—	245,000
2022-10-10	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Chief Legal Officer	AAward	+715K sh	—	—	715,000
2022-01-31	Gritstone bio, Inc.A Award	EVP and General Counsel	AAward	+19.2K sh	—	—	58,698
2022-01-31	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	EVP and General Counsel	AAward	+115K sh	—	—	115,440
2021-03-08	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	EVP and General Counsel	AAward	+60K sh	—	—	60,000
2021-01-07	Gritstone bio, Inc.A Award	EVP and General Counsel	AAward	+25.5K sh	—	—	29,487
2020-05-13	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	EVP and General Counsel	AAward	+85K sh	—	—	85,000

Recent filings

Accepted (ET)
Aug 174
Thompson Rahsaan0001434647-26-000073
SEC(opens sec.gov)
Jun 234
Thompson Rahsaan0001434647-26-000057
SEC(opens sec.gov)
May 134
Thompson Rahsaan0001434647-26-000034
SEC(opens sec.gov)
Feb 24
Thompson Rahsaan0001788524-26-000002
SEC(opens sec.gov)
Jun 304
Thompson Rahsaan0001437749-25-021577
SEC(opens sec.gov)
Jun 244
Thompson Rahsaan0001437749-25-021183
SEC(opens sec.gov)
Feb 34
Thompson Rahsaan0001437749-25-002628
SEC(opens sec.gov)
Jun 254
Thompson Rahsaan0001437749-24-021191
SEC(opens sec.gov)
Feb 284
Thompson Rahsaan0001209191-23-013839
SEC(opens sec.gov)
Oct 124
Thompson Rahsaan0001209191-22-053457
SEC(opens sec.gov)
Apr 204
Thompson Rahsaan0001567619-22-008723
SEC(opens sec.gov)

Companies

Address

C/O ZEVRA THERAPEUTICS, INC. 101 FEDERAL STREET

BOSTON, MA, 02110